Loading companies…
China · Biotech · AI
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
Anew Labs develops models and software for protein-structure prediction, molecular dynamics, biomolecular design and antibody optimization. Its AnewSampling engine models dynamic protein–ligand interactions rather than relying only on a static structure, while other tools support target analysis and candidate design.
The company combines computational tools with experimental science and wet-lab feedback to advance its own therapeutic programs. Its platform is intended to support the path from target identification through lead optimization and development; the company lists programs including IL-17-family targets and IL4R across its discovery pipeline.
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Funding | $290M | 5Y Capital — LeadGL Ventures — LeadHSG — LeadIDG Capital — LeadBoyu Capital — ParticipantGaorong Ventures — ParticipantPrimavera Venture Partners — ParticipantSBP Group — ParticipantShanghai Future Industries Fund — Participant |